Article(id=1322180234980470864, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322180233244038010, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1626105600000, acceptedDateStr=2021-07-13, onlineDate=1793161932940, onlineDateStr=2026-10-28, pubDate=1631635200000, pubDateStr=2021-09-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793161932940, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793161932940, creator=13701087609, updateTime=1793161932940, updator=13701087609, issue=Issue{id=1322180233244038010, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='17', pageStart='1537', pageEnd='1632', issueExtLink='null', onlineDate='null', pubDate='1631635200000', pubDateStr='2021-09-15', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1793161932525, creator='13701087609', updateTime=1793162118166, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322181011941732619, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322180233244038010, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322181011945926924, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322180233244038010, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1559, endPage=1564, ext={EN=ArticleExt(id=1322180235185991761, articleId=1322180234980470864, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Analysis of performance-based risk-sharing agreements of the Cancer Drug Fund in the United Kingdom, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

With the optimization of drug evaluation and approval system in China, an increasing number of “global new” innovative drugs, especially those with conditional approval, are being marketed in China. For such drugs that have not yet accumulated sufficient evidence in real world, urgent problems, such as how to balance clinical needs with the risks of medical insurance funds and scientific designing of medical insurance access plans, are yet to be solved by China medical insurance departments. While in the United Kingdom (UK), the Cancer Drugs Fund (CDF) has been set up since 2011, which specializes in compensation for anticancer drugs. Through the managed access agreements (MAAs) signed with drug manufacturers, CDF regularly collects and evaluates the real-world therapeutic data, and decides whether to include or withdraw this anticancer drug in the reimbursement scope of the National Health Service (NHS), solving the “uncertainty of drug therapeutic effect” potently. This paper analyzes the operation mode, drug types, and agreement elements of the MAAs implemented by the CDF in recent years in order to provide a reference for the medical insurance management of high-value innovative drugs reimbursement accessing in China.

, authors=Wei LI1, 2, Hui SHI1, Jin-xi DING1, 2, Xiao-ling ZHENG1, authorsList=Wei LI, Hui SHI, Jin-xi DING, Xiao-ling ZHENG, authorCompany=null, correspAuthors=Jin-xi DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322180235496370258, articleId=1322180234980470864, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=英国癌症药物基金的疗效风险分担协议分析, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

随着我国药品注册审评体系的优化,愈来愈多的“全球新”创新药,尤其是附条件审批上市的创新药在我国加快上市,对于此类在真实世界尚未积累充分证据的药品,如何平衡临床需求与医保基金风险、科学设计医保准入方案,是我国医保部门亟待解决的问题。英国自2011年起成立了专门针对癌症药物进行补偿的英国癌症药物基金(Cancer Drugs Fund,CDF),通过与药品生产企业签订的管理准入协议(managed access agreement,MAA),收集真实世界的疗效数据、定期评估后决定是否将该抗癌药物纳入国民健康服务体系(National Health Service,NHS)的常规报销或退出补偿范围,从而解决其“疗效不确定性”。本文通过对CDF实行的MAA协议的运行模式、药品种类、协议要素进行分析,为我国医保部门在准入高值创新药物的医保管理方面提供一定参考。

, authors=李伟1, 2, 施慧1, 丁锦希1, 2, 郑晓玲1, authorsList=李伟, 施慧, 丁锦希, 郑晓玲, authorCompany=null, correspAuthors=丁锦希, authorNote=

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

, correspAuthorsNote=
丁锦希,男,教授,博士生导师,主要从事医药政策法规、医药市场准入与药物经济学研究。联系电话:(025)86185287,E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=1JKoNolCigqDkISxpVOgig==, magXml=u8WZQ91wjJcTmR8mRYkPVw==, pdfUrl=null, pdf=8iqzs+LNl9OQYix5amkmwA==, pdfFileSize=1452371, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=AKRUeTPNt34hDLXWycuybQ==, mapNumber=null, fund=null)}, authors=[Author(id=1322180235899023450, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=cpuliwei@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180235987103837, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180235899023450, language=EN, stringName=Wei LI, firstName=Wei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236054212702, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180235899023450, language=CN, stringName=李伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1中国药科大学国际医药商学院,南京 211198
2中国药科大学医药市场准入政策研究中心,南京 211198, bio={"content":"

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

"}, bioImg=null, bioContent=

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)]), AuthorCompany(id=1322180235798360150, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=2, ext=[AuthorCompanyExt(id=1322180235806748759, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235815137368, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2中国药科大学医药市场准入政策研究中心,南京 211198)])]), Author(id=1322180236142293088, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180236230373474, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236142293088, language=EN, stringName=Hui SHI, firstName=Hui, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236314259555, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236142293088, language=CN, stringName=施慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国药科大学国际医药商学院,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)])]), Author(id=1322180236381368421, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=13605152326@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322180236553334888, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236381368421, language=EN, stringName=Jin-xi DING, firstName=Jin-xi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236645609577, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236381368421, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1中国药科大学国际医药商学院,南京 211198
2中国药科大学医药市场准入政策研究中心,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)]), AuthorCompany(id=1322180235798360150, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=2, ext=[AuthorCompanyExt(id=1322180235806748759, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235815137368, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2中国药科大学医药市场准入政策研究中心,南京 211198)])]), Author(id=1322180236742078571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180236834353261, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236742078571, language=EN, stringName=Xiao-ling ZHENG, firstName=Xiao-ling, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236964376686, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236742078571, language=CN, stringName=郑晓玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国药科大学国际医药商学院,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)])])], keywords=[Keyword(id=1322180237069234287, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=EN, orderNo=1, keyword=Cancer Drugs Fund (CDF) in the UK), Keyword(id=1322180237144731760, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=EN, orderNo=2, keyword=uncertainty in drug effectiveness), Keyword(id=1322180237228617841, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=EN, orderNo=3, keyword=risk sharing), Keyword(id=1322180237320892530, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=EN, orderNo=4, keyword=operation mechanism), Keyword(id=1322180237392195699, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=EN, orderNo=5, keyword=agreement elements), Keyword(id=1322180237467693172, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=CN, orderNo=1, keyword=英国癌症药物基金), Keyword(id=1322180237538996341, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=CN, orderNo=2, keyword=疗效不确定性), Keyword(id=1322180237610299510, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=CN, orderNo=3, keyword=风险分担), Keyword(id=1322180237673214071, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=CN, orderNo=4, keyword=运行模式), Keyword(id=1322180237761294456, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, language=CN, orderNo=5, keyword=协议要素)], refs=[Reference(id=1322180238054895739, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心. 2019年度药品审评报告[EB/OL]. [2020-07-30]. http://www.cde.org.cn/news.do?method=changePage&pageName=service&frameStr=24., articleTitle=null, refAbstract=null), Reference(id=1322180238122004604, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=NHS. NHS Commercial Framework for Medicines[EB/OL]. [2021-02-07]. https://www.engage.england.nhs.uk/consultation/nhs-commercial-framework-for-medicines/user_uploads/commercial-framework-001218.pdf., articleTitle=null, refAbstract=null), Reference(id=1322180238193307773, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=NICE. Cancer Drugs Fund-Glossary of terms[EB/OL]. [2021-02-07]. https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/cdf-glossary-of-terms.pdf., articleTitle=null, refAbstract=null), Reference(id=1322180238272999550, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=NHS. National Cancer Drugs Fund list[EB/OL]. [2021-02-07]. https://www.england.nhs.uk/publication/national-cancer-drugs-fund-list., articleTitle=null, refAbstract=null), Reference(id=1322180238340108415, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=NICE. Guidance and advice list[EB/OL]. [2021-02-07]. https://www.nice.org.uk/guidance/published?type=ta., articleTitle=null, refAbstract=null), Reference(id=1322180238419800192, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Office for National Statistics. Cancer registration statistics[EB/OL]. [2021-02-07]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2017., articleTitle=null, refAbstract=null), Reference(id=1322180238499491969, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SACT. About SACT[EB/OL]. [2021-02-07]. http://www.chemodataset.nhs.uk/home., articleTitle=null, refAbstract=null), Reference(id=1322180238570795138, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Genomics England. About Genomics England[EB/OL]. [2021-02-07]. https://www.genomicsengland.co.uk/about-genomics-england/., articleTitle=null, refAbstract=null), Reference(id=1322180238658875523, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ERM EURACAN. Ern Background[EB/OL]. [2021-02-07]. https://euracan.ern-net.eu/., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322180237878734969, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, awardId=CPU2018GY4, language=CN, fundingSource=中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4), fundOrder=null, country=null), Fund(id=1322180237945843834, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, awardId=2019SJA0063, language=CN, fundingSource=江苏省教育厅2019年度高校哲学社会科学研究一般项目(2019SJA0063), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)]), AuthorCompany(id=1322180235798360150, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=2, ext=[AuthorCompanyExt(id=1322180235806748759, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235815137368, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2中国药科大学医药市场准入政策研究中心,南京 211198)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I17/1559, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I17/1559, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I17/1559, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I17/1559, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1631635200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
英国癌症药物基金的疗效风险分担协议分析
收藏切换
PDF下载
李伟 1, 2 , 施慧 1 , 丁锦希 1, 2 , 郑晓玲 1
中国新药杂志 | 新药述评与论坛 2021,30(17): 1559-1564
收起
收藏切换
中国新药杂志 |新药述评与论坛 2021 , 30 (17) : 1559 -1564
英国癌症药物基金的疗效风险分担协议分析
全屏
[Author(id=1322180235899023450, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=cpuliwei@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180235987103837, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180235899023450, language=EN, stringName=Wei LI, firstName=Wei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236054212702, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180235899023450, language=CN, stringName=李伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1中国药科大学国际医药商学院,南京 211198
2中国药科大学医药市场准入政策研究中心,南京 211198, bio={"content":"

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

"}, bioImg=null, bioContent=

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)]), AuthorCompany(id=1322180235798360150, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=2, ext=[AuthorCompanyExt(id=1322180235806748759, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235815137368, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2中国药科大学医药市场准入政策研究中心,南京 211198)])]), Author(id=1322180236142293088, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180236230373474, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236142293088, language=EN, stringName=Hui SHI, firstName=Hui, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236314259555, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236142293088, language=CN, stringName=施慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国药科大学国际医药商学院,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)])]), Author(id=1322180236381368421, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=13605152326@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322180236553334888, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236381368421, language=EN, stringName=Jin-xi DING, firstName=Jin-xi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236645609577, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236381368421, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1中国药科大学国际医药商学院,南京 211198
2中国药科大学医药市场准入政策研究中心,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)]), AuthorCompany(id=1322180235798360150, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=2, ext=[AuthorCompanyExt(id=1322180235806748759, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235815137368, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235798360150, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2中国药科大学医药市场准入政策研究中心,南京 211198)])]), Author(id=1322180236742078571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322180236834353261, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236742078571, language=EN, stringName=Xiao-ling ZHENG, firstName=Xiao-ling, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322180236964376686, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, authorId=1322180236742078571, language=CN, stringName=郑晓玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1中国药科大学国际医药商学院,南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322180235706085459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, xref=1, ext=[AuthorCompanyExt(id=1322180235718668372, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China), AuthorCompanyExt(id=1322180235731251285, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322180234980470864, companyId=1322180235706085459, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1中国药科大学国际医药商学院,南京 211198)])])]
李伟1, 2 , 施慧1, 丁锦希1, 2 , 郑晓玲1
作者信息
  • 1中国药科大学国际医药商学院,南京 211198
  • 2中国药科大学医药市场准入政策研究中心,南京 211198
通讯作者:
丁锦希,男,教授,博士生导师,主要从事医药政策法规、医药市场准入与药物经济学研究。联系电话:(025)86185287,E-mail:。
作者简介:

李伟,男,讲师,博士研究生在读,主要从事医药市场准入与医疗保障政策研究。E-mail:。

Analysis of performance-based risk-sharing agreements of the Cancer Drug Fund in the United Kingdom
Wei LI1, 2 , Hui SHI1, Jin-xi DING1, 2 , Xiao-ling ZHENG1
Affiliations
  • 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
  • 2Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, China
出版时间: 2021-09-15
文章导航
收藏切换

随着我国药品注册审评体系的优化,愈来愈多的“全球新”创新药,尤其是附条件审批上市的创新药在我国加快上市,对于此类在真实世界尚未积累充分证据的药品,如何平衡临床需求与医保基金风险、科学设计医保准入方案,是我国医保部门亟待解决的问题。英国自2011年起成立了专门针对癌症药物进行补偿的英国癌症药物基金(Cancer Drugs Fund,CDF),通过与药品生产企业签订的管理准入协议(managed access agreement,MAA),收集真实世界的疗效数据、定期评估后决定是否将该抗癌药物纳入国民健康服务体系(National Health Service,NHS)的常规报销或退出补偿范围,从而解决其“疗效不确定性”。本文通过对CDF实行的MAA协议的运行模式、药品种类、协议要素进行分析,为我国医保部门在准入高值创新药物的医保管理方面提供一定参考。

英国癌症药物基金  /  疗效不确定性  /  风险分担  /  运行模式  /  协议要素

With the optimization of drug evaluation and approval system in China, an increasing number of “global new” innovative drugs, especially those with conditional approval, are being marketed in China. For such drugs that have not yet accumulated sufficient evidence in real world, urgent problems, such as how to balance clinical needs with the risks of medical insurance funds and scientific designing of medical insurance access plans, are yet to be solved by China medical insurance departments. While in the United Kingdom (UK), the Cancer Drugs Fund (CDF) has been set up since 2011, which specializes in compensation for anticancer drugs. Through the managed access agreements (MAAs) signed with drug manufacturers, CDF regularly collects and evaluates the real-world therapeutic data, and decides whether to include or withdraw this anticancer drug in the reimbursement scope of the National Health Service (NHS), solving the “uncertainty of drug therapeutic effect” potently. This paper analyzes the operation mode, drug types, and agreement elements of the MAAs implemented by the CDF in recent years in order to provide a reference for the medical insurance management of high-value innovative drugs reimbursement accessing in China.

Cancer Drugs Fund (CDF) in the UK  /  uncertainty in drug effectiveness  /  risk sharing  /  operation mechanism  /  agreement elements
李伟, 施慧, 丁锦希, 郑晓玲. 英国癌症药物基金的疗效风险分担协议分析. 中国新药杂志, 2021 , 30 (17) : 1559 -1564 .
Wei LI, Hui SHI, Jin-xi DING, Xiao-ling ZHENG. Analysis of performance-based risk-sharing agreements of the Cancer Drug Fund in the United Kingdom[J]. Chinese Journal of New Drugs, 2021 , 30 (17) : 1559 -1564 .
  • 中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4)
  • 江苏省教育厅2019年度高校哲学社会科学研究一般项目(2019SJA0063)
参考文献 引证文献
排序方式:
[1]
国家药品监督管理局药品审评中心. 2019年度药品审评报告[EB/OL]. [2020-07-30]. http://www.cde.org.cn/news.do?method=changePage&pageName=service&frameStr=24.
[2]
NHS. NHS Commercial Framework for Medicines[EB/OL]. [2021-02-07]. https://www.engage.england.nhs.uk/consultation/nhs-commercial-framework-for-medicines/user_uploads/commercial-framework-001218.pdf.
[3]
NICE. Cancer Drugs Fund-Glossary of terms[EB/OL]. [2021-02-07]. https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/cdf-glossary-of-terms.pdf.
[4]
NHS. National Cancer Drugs Fund list[EB/OL]. [2021-02-07]. https://www.england.nhs.uk/publication/national-cancer-drugs-fund-list.
[5]
NICE. Guidance and advice list[EB/OL]. [2021-02-07]. https://www.nice.org.uk/guidance/published?type=ta.
[6]
Office for National Statistics. Cancer registration statistics[EB/OL]. [2021-02-07]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2017.
[7]
SACT. About SACT[EB/OL]. [2021-02-07]. http://www.chemodataset.nhs.uk/home.
[8]
Genomics England. About Genomics England[EB/OL]. [2021-02-07]. https://www.genomicsengland.co.uk/about-genomics-england/.
[9]
ERM EURACAN. Ern Background[EB/OL]. [2021-02-07]. https://euracan.ern-net.eu/.
2021年第30卷第17期
PDF下载
15
3
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-28
  • 出版时间:2021-09-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2021-07-13
基金
中国药科大学“双一流”学科创新团队建设项目(CPU2018GY4)
江苏省教育厅2019年度高校哲学社会科学研究一般项目(2019SJA0063)
作者信息
    1中国药科大学国际医药商学院,南京 211198
    2中国药科大学医药市场准入政策研究中心,南京 211198

通讯作者:

丁锦希,男,教授,博士生导师,主要从事医药政策法规、医药市场准入与药物经济学研究。联系电话:(025)86185287,E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322180234980470864
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏